Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells

Autoimmunity Reviews

Volumn 7, Issue 2, 2007, Pages 102-108

  Efremov, Dimitar G ^a   Gobessi, Stefania ^a   Longo, Pablo G ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Akt; B cell receptor; Chronic lymphocytic leukemia; ERK; Syk; ZAP 70

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; PROTEIN MCL 1; X LINKED INHIBITOR OF APOPTOSIS;

B LYMPHOCYTE; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

B-LYMPHOCYTES; GENES, IMMUNOGLOBULIN; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 36148978171     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.02.021     Document Type: Review

References (40)

1. Ferrarini M., and Chiorazzi N. Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia. Semin Hematol 41 (2004) 207-223
2. Stevenson F.K., and Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103 (2004) 4389-4395
3. Klein U., and Dalla-Favera R. New insights into the phenotype and cell derivation of B cell chronic lymphocytic leukemia. Curr Top Microbiol Immunol 294 (2005) 31-49
4. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840-1847
5. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., and Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94 (1999) 1848-1854
6. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194 (2001) 1639-1647
7. Rassenti L.Z., Huynh L., Toy T.L., Chen L., Keating M.J., Gribben J.G., et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351 (2004) 893-901
8. Lanham S., Hamblin T., Oscier D., Ibbotson R., Stevenson F., and Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 101 (2003) 1087-1093
9. Herve M., Xu K., Ng Y.S., Wardemann H., Albesiano E., Messmer B.T., et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 115 (2005) 1636-1643
10. Brdicka T., Kadlecek T.A., Roose J.P., Pastuszak A.W., and Weiss A. Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases. Mol Cell Biol 25 (2005) 4924-4933
11. Niiro H., and Clark E.A. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2 (2002) 945-956
12. Jun J.E., and Goodnow C.C. Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nat Immunol 4 (2003) 1057-1064
13. Healy J.I., Dolmetsch R.E., Timmerman L.A., Cyster J.G., Thomas M.L., Crabtree G.R., et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6 (1997) 419-428
14. Hivroz C., Geny B., Brouet J.C., and Grillot-Courvalin C. Altered signal transduction secondary to surface IgM cross-linking on B-chronic lymphocytic leukemia cells. Differential activation of the phosphatidylinositol-specific phospholipase C. J Immunol 144 (1990) 2351-2358
15. Michel F., Merle-Beral H., Legac E., Michel A., Debre P., and Bismuth G. Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. J Immunol 150 (1993) 3624-3633
16. Lankester A.C., van Schijndel G.M., van der Schoot C.E., van Oers M.H., van Noesel C.J., and van Lier R.A. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood 86 (1995) 1090-1097
17. Semichon M., Merle-Beral H., Lang V., and Bismuth G. Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells. Leukemia 11 (1997) 1921-1928
18. Zupo S., Isnardi L., Megna M., Massara R., Malavasi F., Dono M., et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 88 (1996) 1365-1374
19. Chen L., Widhopf G., Huynh L., Rassenti L., Rai K.R., Weiss A., et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 100 (2002) 4609-4614
20. Mockridge C.I., Potter K.N., Wheatley I., Neville L.A., Packham G., and Stevenson F.K. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood (Jan 25 2007) [Electronic publication ahead of print]
21. Petlickovski A., Laurenti L., Li X., Marietti S., Chiusolo P., Sica S., et al. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B-cells. Blood 105 (2005) 4820-4827
22. Longo P.G., Laurenti L., Gobessi S., Petlickovski A., Pelosi M., Chiusolo P., et al. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia 21 (2007) 110-120
23. Wong S.C., Chew W.K., Tan J.E., Melendez A.J., Francis F., and Lam K.P. Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J Biol Chem 277 (2002) 30707-30715
24. Allsup D.J., Kamiguti A.S., Sherrington P.D., Matrai Z., Slupsky J.R., Cawley J.C., et al. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia. Cancer Res 65 (2005) 7328-7337
25. Messmer B.T., Albesiano E., Efremov D.G., Ghiotto F., Allen S.L., Kolitz J., et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200 (2004) 519-525
26. Tobin G., Thunberg U., Karlsson K., Murray F., Laurell A., Willander K., et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104 (2004) 2879-2885
27. Widhopf II G.F., Rassenti L.Z., Toy T.L., Gribben J.G., Wierda W.G., and Kipps T.J. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104 (2004) 2499-2504
28. Deglesne P.A., Chevallier N., Letestu R., Baran-Marszak F., Beitar T., Salanoubat C., et al. Ajchenbaum-Cymbalista F. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. Cancer Res 15 66 (2006) 7158-7166
29. Kitada S., Andersen J., Akar S., Zapata J.M., Takayama S., Krajewski S., et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91 (1998) 3379-3389
30. Chu D.H., Morita C.T., and Weiss A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev 165 (1998) 167-180
31. Scielzo C., Camporeale A., Geuna M., Alessio M., Poggi A., Zocchi M.R., et al. ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage. Leukemia 20 (2006) 689-695
32. Cutrona G., Colombo M., Matis S., Reverberi D., Dono M., Tarantino V., et al. B lymphocytes in humans express ZAP-70 when activated in vivo. Eur J Immunol 36 (2006) 558-569
33. Chen L., Apgar J., Huynh L., et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 105 (2005) 2036-2041
34. Gobessi S., Laurenti L., Longo P.G., Sica S., Leone G., and Efremov D.G. ZAP-70 enhances B-cell receptor signaling in spite of absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B-cells. Blood (Oct 12 2006) [Electronic publication ahead of print]
35. Monroe J.G. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol 6 (2006) 283-294
36. Kraus M., Alimzhanov M.B., Rajewsky N., and Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 117 (2004) 787-800
37. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5 (2005) 251-262
38. Gururajan M., Jennings C.D., and Bondada S. Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma. J Immunol 176 (2006) 5715-5719
39. Leseux L., Hamdi S.M., al Saati T., Capilla F., Recher C., Laurent G., et al. Syk-dependent mTOR activation in follicular lymphoma cells. Blood 108 (2006) 4156-4162
40. Contri A., Brunati A.M., Trentin L., Cabrelle A., Miorin M., Cesaro L., et al. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 115 (2005) 369-378